Under construction – not a live service
Sign in
Taking people in EgyptNo phase

Finding Early Brain Lesions in Multiple Sclerosis With a Special MRI

Compares a special MRI scan with standard scans in people with multiple sclerosis.

Plain-language title generated from the registry record
Registry title: Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI

Key facts

Where
Banhā and Cairo, EgyptSee the 3 sites

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 15 and 65 years old?

Source: NCT06955832, who can take part

Where in Egypt

  • Banha University HospitalsBanhā, EgyptTaking people
  • El Mounira Multiple Sclerosis UnitCairo, EgyptTaking people
  • Naser Institute MS UnitCairo, EgyptTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Benha University
Trial code
NCT06955832
Record updated
18 May 2025
Original description
The goal of this observational study is to compare the diagnostic accuracy of Phase-Sensitive Inversion Recovery (PSIR) MRI versus conventional T2-weighted (T2W) and Fluid Attenuated Inversion Recovery (FLAIR) sequences in detecting early brain lesions in patients with Multiple Sclerosis (MS). The study will include male and female participants aged 15-65 years diagnosed with MS per the 2017 McDonald criteria.Read full original descriptionShow less

Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI: A Cross-sectional Study

The goal of this observational study is to compare the diagnostic accuracy of Phase-Sensitive Inversion Recovery (PSIR) MRI versus conventional T2-weighted (T2W) and Fluid Attenuated Inversion Recovery (FLAIR) sequences in detecting early brain lesions in patients with Multiple Sclerosis (MS). The study will include male and female participants aged 15-65 years diagnosed with MS per the 2017 McDonald criteria.

This study hypothesizes that:

* PSIR MRI will detect a significantly higher number of cortical lesions (intracortical, leukocortical, and juxtacortical) compared to conventional T2W and FLAIR sequences in MS patients (p < 0.05). * Lesions identified exclusively by PSIR will correlate more strongly with clinical measures (EDSS disability scores and SDMT cognitive performance) than those detected by T2W/FLAIR alone, suggesting PSIR's superior sensitivity to clinically relevant pathology.

Inclusion: Age between 15-65 years; Both sexes; Patients with MS according to McDonald Criterion.

Exclusion: Patients with stroke or previous intracranial hemorrhage; Age less than 15 years old; Contraindications to MRI scans; MS mimics.

ClinicalTrials.gov NCT06955832